BCL-2 Function in Endoplasmic Reticulum
BCL-2 Function in Endoplasmic Reticulum
批准号:
7192491
负责人:
CLARK W DISTELHORST
金额:
$24.66万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-02-03 至 2010-01-31
关键词:
ApoptosisCalcineurinCalpainCell CycleCyclin-Dependent Kinase InhibitorDockingElevationEndoplasmic ReticulumEventFluorescence Resonance Energy TransferGoalsIn VitroInositolLaboratoriesLocationMediatingMitochondriaMolecularMutationNuclear TranslocationPhosphorylationPhysiologicalProtein DephosphorylationProtein phosphataseProteinsReceptor ActivationRoleSignal TransductionT-Cell ActivationT-Cell ReceptorTechniquesTestingbaseconceptfascinatein vivoinositol-1,4,5-triphosphate receptorinsightmutantnovelreceptortranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Bcl-2 is a fascinating protein that regulates both cell cycle entry and apoptosis through its location on the mitochondria and the endoplasmic reticulum (ER). Although much is known about its role on mitochondria, little is known about its role on the ER. This proposal investigates the novel concept that Bcl-2 regulates intracellular Ca2+ signals involved in cell cycle entry and apoptosis. This concept is based on the recent discovery in this laboratory that Bcl-2 interacts with inositol 1,4,5- trisphosphate (IP3) receptors and reduces IP3-mediated Ca2+ release from the ER. The first two aims of this proposal investigate the molecular mechanism by which Bcl-2 interacts with IP3 receptors and regulates IP3-mediated Ca2+ release. Aim 1 employs the GST-pulldown technique to test for direct interaction in vitro and FRET analysis to test for direct interaction in vivo. Regardless of whether the interaction is direct or indirect, Aim 2 tests the hypothesis that Bcl-2 regulates IP3 mediated Ca2+ release by docking a protein phosphatase to IP3 receptors, thereby reducing their phosphorylation and decreasing their Ca2+ channel activity. A major goal in Aims 1 & 2 is to identify Bcl-2 mutations that abrogate the inhibitory effect of Bcl-2 on IP3-mediated Ca2+ release. Aim 3 will use these Bcl-2 mutants, along with physiological approaches, to determine if the inhibitory effect of Bcl-2 on IP3-mediated Ca2+ release contributes to its ability to inhibit cell cycle entry and apoptosis during T cell activation. The central hypothesis is that by reducing IP3-mediated Ca2+ elevation, Bcl- 2 inhibits two proximal steps in T cell activation, calcineurin-mediated dephosphorylation and nuclear translocation of the transcription factor NFAT, and calpain-mediated degradation of the cyclin dependent kinase inhibitor p27Kip1. Overall, the findings of this proposal will provide novel insight into the mechanism of action of Bcl-2.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting PKM2-InsP3R interaction to treat AML
-
批准号:9104123
-
项目类别:
-
资助金额:$22.23万
-
财政年份:2015
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6497990
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6700231
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8458912
-
项目类别:
-
资助金额:$26.74万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8101377
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8207289
-
项目类别:
-
资助金额:$28.44万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7561019
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:6927609
-
项目类别:
-
资助金额:$26.01万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7031020
-
项目类别:
-
资助金额:$25.4万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:8596796
-
项目类别:
-
资助金额:$27.59万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL-2 Function in Endoplasmic Reticulum
-
批准号:7350157
-
项目类别:
-
资助金额:$24.66万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6350441
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6089857
-
项目类别:
-
资助金额:$23.81万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
BCL 2 FUNCTION IN ENDOPLASMIC RETICULUM
-
批准号:6628460
-
项目类别:
-
资助金额:$24.1万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
Bcl-2 function on the endoplasmic reticulum
-
批准号:7984883
-
项目类别:
-
资助金额:$13.03万
-
财政年份:2000
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6626623
-
项目类别:
-
资助金额:$24.36万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6137701
-
项目类别:
-
资助金额:$22.82万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6489172
-
项目类别:
-
资助金额:$23.83万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:6342122
-
项目类别:
-
资助金额:$23.32万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
STRESS RESPONSES AND APOPTOSIS
-
批准号:2731899
-
项目类别:
-
资助金额:$22.97万
-
财政年份:1999
-
负责人:CLARK W DISTELHORST
-
依托单位:
国内基金
海外基金
登录
查看更多内容
热应激通过Ca²⁺/Calcineurin/DRP1轴诱导心肌损伤与室性心律失常的分子机制研究
-
批准号:JCZRQNB202600378
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在B1AR自身抗体诱导心房重构中的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
乳酸通过Ca2+/Calcineurin/TFEB信号轴在氧化应激诱导视网膜退行性变中的作用机制研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:韩小建
-
依托单位:
Ca2+驱动的Calcineurin/LATS1信号重塑糖有氧氧化进程在β1AR自身抗体诱导心房重构中的机制研究
-
批准号:
-
项目类别:青年科学基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:孙华鑫
-
依托单位:
STING-Ca2+-Calcineurin 负反馈环在机体维
持抗病毒天然免疫稳态中的机制研究
-
批准号:Q24H100001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:王宁
-
依托单位:
神经介素U通过NMUR1/calcineurin/NAFT 通路介导ARDS神经免疫环路调控的研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:戚迪
-
依托单位:
神经分泌NMU通过NMUR1/calcineurin/NFAT通路调控ILC2介导的ARDS免疫炎症的效应及机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:王导新
-
依托单位:
Rcan2抑制Calcineurin活性决定尾鳍极性再生的机制研究
-
批准号:32170853
-
项目类别:面上项目
-
资助金额:57万元
-
批准年份:2021
-
负责人:陆辉强
-
依托单位:
Calcineurin/CRTC2轴介导的CD206+MerTK+巨噬细胞-肝细胞互作重塑移植肝糖稳态研究
-
批准号:82171757
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2021
-
负责人:凌琪
-
依托单位:
甲基转移酶 SETD2 调控 Calcineurin 信号抑制线粒体分裂在胶质母细胞瘤细胞增殖与侵袭中的作用及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:
-
依托单位: